Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Nutropin AQ v1.1 in Naïve GHD Children (iSTUDY)
NCT02311894Phase 4Completed
- Sponsor
- Genentech
- Start
- Mar 2015
- Primary completion
- Nov 2017
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of somatropin in growth hormone deficiency (GHD), sponsored by Genentech. Started Mar 2015; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT02311894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311894.